Drug Type Small molecule drug |
Synonyms BMS 986202 |
Target |
Action inhibitors |
Mechanism TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21FN6O3 |
InChIKeyBBRMAVGRWHNAIG-FIBGUPNXSA-N |
CAS Registry1771691-34-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 1 | Australia | 18 May 2016 | |
Acanthosis Nigricans | Preclinical | United States | 28 Dec 2020 | |
Colitis | Preclinical | United States | 28 Dec 2020 |